Sign in

Filings

Finds words inside filing documents. Searching LIGAND PHARMACEUTICALS INC's filings · 50 documents indexed.

19 documents · 21 matches

  1. LGND LIGAND PHARMACEUTICALS INC 10-Q 2026-10-30

    Item 6. Exhibits

    tariffs imposed on the import of certain goods into the U.S. from various countries, as well as other statements that
    1 match in this document

  2. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-10-29

    tariffs and ongoing or future litigation could expose Ligand to significant liabilities and have a material adverse effect on the Company
    1 match in this document

  3. LGND LIGAND PHARMACEUTICALS INC 10-Q 2026-08-07

    Item 6. Exhibits

    tariffs imposed on the import of certain goods into the U.S. from various countries, as well as other statements that
    1 match in this document

  4. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-08-06

    tariffs and ongoing or future litigation could expose Ligand to significant liabilities and have a material adverse effect on the Company
    1 match in this document

  5. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-07-14

    tariffs and other trade policies or economies generally; future business combinations or disposals; uncertainties regarding the commercial success of commercialized
    1 match in this document

  6. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-05-18

    Item 1.01.

    tariffs and other trade policies or economies generally; future business combinations or disposals; uncertainties regarding the commercial success of XOMA
    1 match in this document

  7. LGND LIGAND PHARMACEUTICALS INC 10-Q 2026-05-08

    Item 6. Exhibits

    tariffs imposed on the import of certain goods into the U.S. from various countries, as well as other statements that
    1 match in this document

  8. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-05-07

    tariffs and ongoing or future litigation could expose Ligand to significant liabilities and have a material adverse effect on the Company
    1 match in this document

  9. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-04-27

    Item 8.01.

    tariffs and other trade policies or economies generally; future business combinations or disposals; uncertainties regarding the commercial success of XOMA
    1 match in this document

  10. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-04-27

    tariffs and other trade policies or economies generally; future business combinations or disposals; uncertainties regarding the commercial success of XOMA
    1 match in this document

  11. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-04-27

    tariffs and other trade policies or economies generally; future business combinations or disposals; uncertainties regarding the commercial success of XOMA
    1 match in this document

  12. LGND LIGAND PHARMACEUTICALS INC 10-K 2026-02-27

    Item 1A. Risk Factors

    tariffs or trade restrictions at one or more of these locations, it could lead to supply interruptions. In addition, we rely
    3 matches in this document

  13. LGND LIGAND PHARMACEUTICALS INC 10-Q 2025-11-07

    Item 6. Exhibits

    tariffs imposed on the import of certain goods into the U.S. from various countries, as well as other statements that
    1 match in this document

  14. LGND LIGAND PHARMACEUTICALS INC 8-K 2025-11-06

    tariffs and ongoing or future litigation could expose Ligand to significant liabilities and have a material adverse effect on the Company
    1 match in this document

  15. LGND LIGAND PHARMACEUTICALS INC 10-Q 2025-08-08

    Item 6. Exhibits

    tariffs imposed on the import of certain goods into the U.S. from various countries, as well as other statements that
    1 match in this document

  16. LGND LIGAND PHARMACEUTICALS INC 8-K 2025-08-07

    tariffs and ongoing or future litigation could expose Ligand to significant liabilities and have a material adverse effect on the Company
    1 match in this document

  17. LGND LIGAND PHARMACEUTICALS INC 8-K 2025-07-02

    Item 9.01. Financial Statements and Exhibits.

    tariffs, and ongoing or future litigation could expose us to significant liabilities and have a material adverse effect on us. These
    1 match in this document

  18. LGND LIGAND PHARMACEUTICALS INC 8-K 2025-07-02

    tariffs, and ongoing or future litigation could expose us to significant liabilities and have a material adverse effect on us. These
    1 match in this document

  19. LGND LIGAND PHARMACEUTICALS INC 10-Q 2025-05-09

    Item 6. Exhibits

    tariffs imposed on the import of certain goods into the U.S. from various countries, as well as other statements that
    1 match in this document

Page 1 of 1 · 19 documents